Omega-3 Derived Compound May Help Protect Blood Vessels in the Lungs
This laboratory study looked at Resolvin D1 (RvD1), a molecule the body makes from the omega-3 fat DHA, and its effects on pulmonary hypertension—a condition where blood pressure rises in the lung’s arteries due to thickening and remodeling of the vessel walls.
Using mice exposed to low oxygen and a drug that triggers pulmonary hypertension, along with lab-grown lung artery muscle cells, researchers found that RvD1 reduced harmful changes in blood vessel structure and heart strain. A key mechanism involved a protein called connexin 43 (Cx43), which forms communication channels between cells. Under hypoxic stress, these channels increased and helped spread signals that drove inflammation, oxidative stress, and abnormal cell growth throughout the vessel wall.
RvD1 reduced this pathological channel formation, and when researchers used a different compound to force the channels back open, RvD1’s protective effects were weakened. This suggests that limiting these cell-to-cell communication channels is an important part of how RvD1 helps protect lung blood vessels.
What this means for you
This early-stage animal and cell research adds to the understanding of how DHA-derived compounds like Resolvin D1 may influence blood vessel health at a cellular level, but it does not establish effects in humans and should not be interpreted as evidence that omega-3 supplements treat or prevent pulmonary hypertension.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Frontiers in pharmacology · 2026-01-01 · DOI: 10.3389/fphar.2026.1940174
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.